on SYNLAB
SYNLAB's Strategic Expansion in Italy Enhances Diagnostic Precision
SYNLAB, a leader in European medical diagnostic services, has announced a significant investment in Italy. The company is pioneering the installation of a photon-counting CT scanner at its Naples research center. This move exemplifies SYNLAB's commitment to providing cutting-edge diagnostics and enhancing patient experience.
Photon-counting CT represents a breakthrough in radiology, improving imaging with ultra-high resolution and minimizing radiation exposure. This technology, integrated with advanced AI, aims to enhance image quality, speed up reporting, and provide more accurate diagnostics. It is crucial for complex cases like coronary disease and tumor staging, offering clinicians detailed insights for timely decisions.
SYNLAB has invested over €9 million in Italy's imaging diagnostics in recent years, further solidifying its position as a key diagnostic partner in the region.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SYNLAB news